Figure 2From: Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrineUV chromatogram of a mixed sample illustrating lumefantrine N-oxide, lumefantrine DBK and desbenzyl derivative and lumefantrine. UV chromatogram of a mixed sample illustrating lumefantrine N-oxide (3), DBK (4) and desbenzyl lumefantrine derivative (5) and lumefantrine (L).Back to article page